Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

HIVの症例が米国を震撼させた.

C Chelala

    Lancet (London, England)
    |November 20, 1997
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    The molecular landscape of pancreatic ductal adenocarcinoma.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2022
    Same author

    Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2021
    Same author

    Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

    Leukemia·2016
    Same author

    Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

    Leukemia·2016
    Same author

    Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.

    Oncogene·2014
    Same author

    Yes-associated protein (YAP) functions as a tumor suppressor in breast.

    Cell death and differentiation·2008
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る